Immunic, Inc.
IMUX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $36 | $47 | $107 | $87 |
| Short-Term Investments | $0 | $0 | $10 | $0 |
| Receivables | $1 | $1 | $0 | $2 |
| Inventory | $0 | $0 | $6 | $0 |
| Other Curr. Assets | $3 | $5 | $4 | $16 |
| Total Curr. Assets | $39 | $53 | $126 | $105 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $1 |
| Goodwill | $0 | $0 | $0 | $33 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $2 | $2 | $34 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $41 | $54 | $128 | $139 |
| Liabilities | – | – | – | – |
| Payables | $8 | $5 | $4 | $3 |
| Short-Term Debt | $1 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $14 | $19 | $8 | $7 |
| Total Curr. Liab. | $22 | $25 | $13 | $11 |
| LT Debt | $0 | $1 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $1 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $2 | $1 |
| Total Liabilities | $22 | $25 | $14 | $12 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$511 | -$411 | -$317 | -$197 |
| AOCI | $4 | $4 | $3 | -$0 |
| Other Equity | $526 | $436 | $428 | $324 |
| Total Equity | $18 | $29 | $114 | $127 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $41 | $54 | $128 | $139 |
| Net Debt | -$35 | -$45 | -$105 | -$86 |